608 related articles for article (PubMed ID: 17400654)
1. Loss of MMP-2 disrupts skeletal and craniofacial development and results in decreased bone mineralization, joint erosion and defects in osteoblast and osteoclast growth.
Mosig RA; Dowling O; DiFeo A; Ramirez MC; Parker IC; Abe E; Diouri J; Aqeel AA; Wylie JD; Oblander SA; Madri J; Bianco P; Apte SS; Zaidi M; Doty SB; Majeska RJ; Schaffler MB; Martignetti JA
Hum Mol Genet; 2007 May; 16(9):1113-23. PubMed ID: 17400654
[TBL] [Abstract][Full Text] [Related]
2. Loss of MMP-2 in murine osteoblasts upregulates osteopontin and bone sialoprotein expression in a circuit regulating bone homeostasis.
Mosig RA; Martignetti JA
Dis Model Mech; 2013 Mar; 6(2):397-403. PubMed ID: 22917927
[TBL] [Abstract][Full Text] [Related]
3. Type I collagen is a genetic modifier of matrix metalloproteinase 2 in murine skeletal development.
Egeblad M; Shen HC; Behonick DJ; Wilmes L; Eichten A; Korets LV; Kheradmand F; Werb Z; Coussens LM
Dev Dyn; 2007 Jun; 236(6):1683-93. PubMed ID: 17440987
[TBL] [Abstract][Full Text] [Related]
4. Osteoclast deficiency results in disorganized matrix, reduced mineralization, and abnormal osteoblast behavior in developing bone.
Dai XM; Zong XH; Akhter MP; Stanley ER
J Bone Miner Res; 2004 Sep; 19(9):1441-51. PubMed ID: 15312244
[TBL] [Abstract][Full Text] [Related]
5. A crucial role for matrix metalloproteinase 2 in osteocytic canalicular formation and bone metabolism.
Inoue K; Mikuni-Takagaki Y; Oikawa K; Itoh T; Inada M; Noguchi T; Park JS; Onodera T; Krane SM; Noda M; Itohara S
J Biol Chem; 2006 Nov; 281(44):33814-24. PubMed ID: 16959767
[TBL] [Abstract][Full Text] [Related]
6. Osteoblast extracellular Ca2+ -sensing receptor regulates bone development, mineralization, and turnover.
Dvorak-Ewell MM; Chen TH; Liang N; Garvey C; Liu B; Tu C; Chang W; Bikle DD; Shoback DM
J Bone Miner Res; 2011 Dec; 26(12):2935-47. PubMed ID: 21956637
[TBL] [Abstract][Full Text] [Related]
7. Uncoupling of osteoblast-osteoclast regulation in a chemical murine model of Gaucher disease.
Mucci JM; Suqueli García F; de Francesco PN; Ceci R; Di Genaro S; Fossati CA; Delpino MV; Rozenfeld PA
Gene; 2013 Dec; 532(2):186-91. PubMed ID: 24076352
[TBL] [Abstract][Full Text] [Related]
8. Effect of osteoblast-targeted expression of bcl-2 in bone: differential response in male and female mice.
Pantschenko AG; Zhang W; Nahounou M; McCarthy MB; Stover ML; Lichtler AC; Clark SH; Gronowicz GA
J Bone Miner Res; 2005 Aug; 20(8):1414-29. PubMed ID: 16007339
[TBL] [Abstract][Full Text] [Related]
9. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
Kassem M
APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
[TBL] [Abstract][Full Text] [Related]
10. Microtubule assembly affects bone mass by regulating both osteoblast and osteoclast functions: stathmin deficiency produces an osteopenic phenotype in mice.
Liu H; Zhang R; Ko SY; Oyajobi BO; Papasian CJ; Deng HW; Zhang S; Zhao M
J Bone Miner Res; 2011 Sep; 26(9):2052-67. PubMed ID: 21557310
[TBL] [Abstract][Full Text] [Related]
11. An osteoblast-derived proteinase controls tumor cell survival via TGF-beta activation in the bone microenvironment.
Thiolloy S; Edwards JR; Fingleton B; Rifkin DB; Matrisian LM; Lynch CC
PLoS One; 2012; 7(1):e29862. PubMed ID: 22238668
[TBL] [Abstract][Full Text] [Related]
12. Mutation of the matrix metalloproteinase 2 gene (MMP2) causes a multicentric osteolysis and arthritis syndrome.
Martignetti JA; Aqeel AA; Sewairi WA; Boumah CE; Kambouris M; Mayouf SA; Sheth KV; Eid WA; Dowling O; Harris J; Glucksman MJ; Bahabri S; Meyer BF; Desnick RJ
Nat Genet; 2001 Jul; 28(3):261-5. PubMed ID: 11431697
[TBL] [Abstract][Full Text] [Related]
13. Al-Aqeel Sewairi syndrome, a new autosomal recessive disorder with multicentric osteolysis, nodulosis and arthropathy. The first genetic defect of matrix metalloproteinase 2 gene.
Al-Aqeel AI
Saudi Med J; 2005 Jan; 26(1):24-30. PubMed ID: 15756348
[TBL] [Abstract][Full Text] [Related]
14. Treatment with anti-gamma-glutamyl transpeptidase antibody attenuates osteolysis in collagen-induced arthritis mice.
Ishizuka Y; Moriwaki S; Kawahara-Hanaoka M; Uemura Y; Serizawa I; Miyauchi M; Shibata S; Kanaya T; Takata T; Taniguchi N; Niida S
J Bone Miner Res; 2007 Dec; 22(12):1933-42. PubMed ID: 17680722
[TBL] [Abstract][Full Text] [Related]
15. Sialic acid-binding immunoglobulin-like lectin 15 (Siglec-15) mediates periarticular bone loss, but not joint destruction, in murine antigen-induced arthritis.
Shimizu T; Takahata M; Kameda Y; Endo T; Hamano H; Hiratsuka S; Ota M; Iwasaki N
Bone; 2015 Oct; 79():65-70. PubMed ID: 26027508
[TBL] [Abstract][Full Text] [Related]
16. A novel matrix metalloproteinase 2 (MMP2) terminal hemopexin domain mutation in a family with multicentric osteolysis with nodulosis and arthritis with cardiac defects.
Tuysuz B; Mosig R; Altun G; Sancak S; Glucksman MJ; Martignetti JA
Eur J Hum Genet; 2009 May; 17(5):565-72. PubMed ID: 18985071
[TBL] [Abstract][Full Text] [Related]
17. Conditional Deletion of Indian Hedgehog in Limb Mesenchyme Results in Complete Loss of Growth Plate Formation but Allows Mature Osteoblast Differentiation.
Amano K; Densmore MJ; Lanske B
J Bone Miner Res; 2015 Dec; 30(12):2262-72. PubMed ID: 26094741
[TBL] [Abstract][Full Text] [Related]
18. TIEG1 null mouse-derived osteoblasts are defective in mineralization and in support of osteoclast differentiation in vitro.
Subramaniam M; Gorny G; Johnsen SA; Monroe DG; Evans GL; Fraser DG; Rickard DJ; Rasmussen K; van Deursen JM; Turner RT; Oursler MJ; Spelsberg TC
Mol Cell Biol; 2005 Feb; 25(3):1191-9. PubMed ID: 15657444
[TBL] [Abstract][Full Text] [Related]
19. A lack of thyroid hormones rather than excess thyrotropin causes abnormal skeletal development in hypothyroidism.
Bassett JH; Williams AJ; Murphy E; Boyde A; Howell PG; Swinhoe R; Archanco M; Flamant F; Samarut J; Costagliola S; Vassart G; Weiss RE; Refetoff S; Williams GR
Mol Endocrinol; 2008 Feb; 22(2):501-12. PubMed ID: 17932107
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-33, a target of parathyroid hormone and oncostatin m, increases osteoblastic matrix mineral deposition and inhibits osteoclast formation in vitro.
Saleh H; Eeles D; Hodge JM; Nicholson GC; Gu R; Pompolo S; Gillespie MT; Quinn JM
Endocrinology; 2011 May; 152(5):1911-22. PubMed ID: 21363931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
